-
Signature
-
By: /s/ Kathleen A. McGowan For: Wes Kaupinen
-
Issuer symbol
-
PVLA
-
Transactions as of
-
05 Feb 2025
-
Net transactions value
-
$0
-
Form type
-
4/A - Amendment
-
Filing time
-
10 Feb 2025, 18:25:31 UTC
-
Date Of Original Report
-
07 Feb 2025
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PVLA |
Non-Qualified Stock Option (right to buy) |
Award |
$0 |
+243,831 |
|
$0.000000 |
243,831 |
05 Feb 2025 |
Common Stock |
243,831 |
$14.76 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
This amendment is being filed to reflect a change in the reporting person's name from Palvella Therapeutics, Inc to Wes Kaupinen.